3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
2
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Ovarian Neoplasms
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms
1
Interventions
Neoadjuvant Therapy
1
FAPI-46
1
Endosonography
1
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Pancreatic Ductal Adenocarcinoma (PDAC)
×
FAPI-46
×
Clear all
NCT06659705
2026-04-15
INDIGO-FAPI
Institut Curie
Phase 2
Recruiting
35 enrolled